Categories: Wire Stories

Delta-Fly Pharma Inc.: Notice of Authorization to Conduct the Phase I/II Study of DFP-10917 combined with Venetoclax

TOKUSHIMA, Japan–(BUSINESS WIRE)–Following to the previous information on March 11th, 2024, we are excited to share our latest development status.


We are pleased to announce the protocol for the Phase I/II clinical trial of DFP-10917 combined with Venetoclax (VTX) in patients with acute myeloid leukemia (AML) with prior VTX involved one regimen, which was submitted to the FDA in US on March 8 has been approved by the FDA in US dated April 8, 2024. Accordingly, we can start the Phase I/II combo-study very soon.

The aim for conducting this study is to judge if DFP-10917 combined with VTX is to show superiority to the standard chemotherapy (azacitidine combined with VTX) for AML. This combo-study shall be done by major clinical sites in US like Wake Forest University, expertise with clinical study of novel chemotherapy for AML.

The interim analysis of the Phase III trial of DFP-10917 monotherapy in patients with recurrent or refractory AML is under follow-up for a number of long-term survivors that have a significant impact on the overall survival (OS) analysis. 

Please take notice of our own innovative approach for miserable cancer patients and contact with us.

Contacts

Inquiries

Scott Frank

Vice President for Business Development

Delta-Fly Pharma, Inc.

Head office: Tokushima 771-0117, Japan

Phone: +81-3-6231-1278

E-mail: sfrank1206@delta-flypharma.co.jp
Home page: https://www.delta-flypharma.co.jp/en/

Alex

Recent Posts

Artistic Biomedical Limited Company Garners Two Accolades at the Asia Pacific Enterprise Awards 2024 Taiwan

SINGAPORE - Media OutReach Newswire - 6 November 2024 - Artistic Biomedical Limited Company took…

1 hour ago

Awesome Group Honored With Two Awards at the Asia Pacific Enterprise Awards 2024 Taiwan Chapter

SINGAPORE - Media OutReach Newswire - 6 November 2024 - Leading education & training brand,…

1 hour ago

Asia Responsible Enterprise Awards 2024 China Chapter Shines Light on ESG Champions Setting the Standard for Sustainability in Asia

SHANGHAI, CHINA - Media OutReach Newswire - 6 November 2024 - The Asia Responsible Enterprise…

2 hours ago

China Wantian Holdings was awarded the “2024 Hong Kong International ESG Award”

HONG KONG SAR – Media OutReach Newswire - 6 November 2024 - At the "2024…

4 hours ago

JustMarkets Gala Dinner 2024 — This Year’s Most Splendid and Rewarding Trading Event

KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 6 November 2024 - On the 28th…

5 hours ago

St. George’s University Emphasizes Pathology’s Critical Role in Advancing South Korea’s Healthcare Systems on World Pathology Day

SEOUL, SOUTH KOREA - Media OutReach Newswire - 6 November 2024 - On World Pathology…

6 hours ago